"Chemists have long had to choose between these two stalwart reaction classes, both presenting marked advantages, but also shortcomings," say Baran,
holder of the Darlene Shiley Chair in Chemistry at Scripps Research. "Combining these two reactions solves this dichotomy by leveraging the strengths
of both to provide a reliable and versatile strategy for producing complex molecules."
C-C cross coupling, a bond-forming method that is highly reliable and controllable, has long been the method of choice in the pharmaceutical industry
for synthesizing the skeletons of drug candidates. However, the method is limited in its ability to construct complex three-dimensional architectures,
resulting in a disproportionate number of flat drug molecules—a characteristic that potentially presents a hurdle to creating new drugs for
increasingly difficult biological targets. Cycloaddition reactions, in contrast, offer the ability to build highly complex 3-D shapes in a single
step, but different types cycloaddition reactions required highly customized preparation, which limited their utility. [1]
[Edited on 24-12-2018 by andy1988] |